A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
Clinical trial NCT06081894 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06081894
- Sponsor
- Cytokinetics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2026-08-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.